China Shineway Pharmaceutical Group Ltd represents a strong set of values and corporate philosophy. The company is committed to delivering high-quality pharmaceutical products and healthcare solutions. With a focus on innovation, they strive to improve the well-being of individuals and communities. China Shineway Pharmaceutical Group Ltd places great importance on research and development, aiming to develop safe and effective medications. They prioritize ethical business practices, promoting transparency and integrity in their operations. By constantly adapting to the changing healthcare landscape, China Shineway Pharmaceutical Group Ltd aims to provide value to their stakeholders and contribute to the advancement of the pharmaceutical industry.

China Shineway Pharmaceutical Group Ltd is primarily present in the People's Republic of China. With its headquarters in Beijing, the company has a strong presence throughout China's major cities and provinces. It operates a widespread network of production facilities, research and development centers, and distribution channels across the country. As a leading pharmaceutical company in China, Shineway also exports its products to various countries and regions around the world. However, its main focus and market presence revolve around serving the domestic market within China.

China Shineway Pharmaceutical Group Ltd, a leading pharmaceutical company, has achieved numerous significant milestones in its journey. Over the years, the company has made remarkable progress in the research, development, and commercialization of innovative pharmaceutical products. China Shineway Pharmaceutical has successfully launched several breakthrough drugs, revolutionizing the treatment options for various medical conditions. Moreover, the company has established strategic collaborations with international partners, expanding its global presence and enhancing its market competitiveness. With a strong commitment to quality and innovation, China Shineway Pharmaceutical continues to excel in the pharmaceutical industry, providing effective and reliable healthcare solutions to patients worldwide.

China Shineway Pharmaceutical Group Ltd, founded in 1996, is a renowned Chinese pharmaceutical company engaged in the research, development, production, and sale of traditional Chinese medicine (TCM) products. With a rich history spanning over two decades, the company has emerged as a leading player in the field of TCM. It focuses on integrating modern scientific research with traditional medicine, aiming to provide safe and effective healthcare solutions. China Shineway Pharmaceutical Group Ltd has established itself as a trusted name in the pharmaceutical industry, constantly striving for innovation and quality in its products.

The main competitors of China Shineway Pharmaceutical Group Ltd in the market include Jiangsu Hengrui Medicine Co., Ltd., Sino Biopharmaceutical Limited, CSPC Pharmaceutical Group Limited, and Shanghai Pharmaceuticals Holding Co., Ltd.

China Shineway Pharmaceutical Group Ltd is primarily active in the pharmaceutical industry. As a leading Chinese pharmaceutical company, China Shineway Pharmaceutical Group Ltd focuses on the research, development, production, and sales of a wide range of pharmaceutical products. With its vast portfolio, the company is dedicated to providing innovative and high-quality medicines to improve global healthcare. China Shineway Pharmaceutical Group Ltd's expertise lies in various therapeutic areas, including cardiovascular diseases, oncology, and infectious diseases. Through its commitment to innovation and excellence, the company continues to make significant contributions to the advancement of the pharmaceutical industry.

The business model of China Shineway Pharmaceutical Group Ltd revolves around developing, manufacturing, and marketing traditional Chinese medicine products. With a focus on herbal medicine research and production, the company strives to provide high-quality healthcare solutions to consumers. By leveraging its robust supply chain, rigorous quality control measures, and extensive distribution network, China Shineway Pharmaceutical Group Ltd aims to cater to the growing demand for traditional medicine both domestically and internationally. Through its commitment to innovation, the company continuously strives to improve medical treatments and enhance the overall well-being of individuals, making it a leading player in the pharmaceutical industry.

مُعامل القيمة السوقية إلى الأرباح لـ China Shineway Pharmaceutical Group هو ٤٫٩٩.

مُعامِل القيمة إلى المبيعات China Shineway Pharmaceutical Group هو ١٫٠٦.

نقاط جودة AlleAktien لـ China Shineway Pharmaceutical Group هي 8/10.

المتوقعة China Shineway Pharmaceutical Group الإيرادات هي ٥٫١٩ مليارات CNY.

صافي الربح المتوقعة China Shineway Pharmaceutical Group هو ١٫١٠ مليارات CNY.

China Shineway Pharmaceutical is one of the largest and leading companies in the Chinese pharmaceutical industry. It was founded in 1996 and is headquartered in Beijing. Shineway's business model is based on research, development, production, and distribution of innovative medicines, health products, and medical technology. The company operates in three main business segments: Authentic Medicine (AM), Modern Chinese Medicine (MCM), and Health Products (HP). Authentic Medicine is the focus of Shineway's business. They offer traditional Chinese medicines as well as other medicines that result from research and development. The AM unit specializes in developing drugs to improve human health. The company understands that they need to be a trusted player in the market and their efforts to comply with international standards prove this. For example, Shineway develops drugs to treat cancer, cardiovascular diseases, infections, and metabolic disorders. The company has partnerships and cooperation agreements with leading academic institutions and biotechnology companies around the world to drive innovation and introduce them to the market. Modern Chinese Medicine (MCM) is Shineway's second major business segment. It combines traditional Chinese medicine (TCM) and Western medicine. Shineway recognizes the advantages of TCM and offers an optimized treatment through various researches, medical studies, and clinical trials. In doing so, Shineway contributes to the improvement of medical care in China and contributes to the coexistence of modern and traditional medicine. Health Products (HP) is Shineway's third business segment. It focuses on the needs and requirements of consumers. Shineway offers a wide range of products tailored to the needs of consumers. This includes products to strengthen the immune system, dietary supplements, and natural remedies. Shineway has presented alternative solutions to traditional Chinese treatment alternatives and offered products to improve quality of life. Overall, Shineway's business model is focused on promoting advancements in medical research and product development as well as improving the medical industry. It combines innovative and traditional approaches, allowing them to be represented in different industries and offer a wide portfolio. Shineway has helped revolutionize the Chinese pharmaceutical industry and establish itself as a trusted market leader in the industry.

يوزع China Shineway Pharmaceutical Group أرباحًا قدرها ٠٫٣٨ CNY من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ China Shineway Pharmaceutical Group في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـChina Shineway Pharmaceutical Group هو KYG2110P1000.

رمز WKN لـ China Shineway Pharmaceutical Group هو A0DNLW.

الرمز المُختصر لـ China Shineway Pharmaceutical Group هو 2877.HK.

خلال آخر 12 شهراً، دفعت China Shineway Pharmaceutical Group توزيعات أرباح بقيمة ٠٫٤٧ CNY . وهذا يعادل عائد توزيعات أرباح يقارب ٦٫٤٩ %. ومن المتوقع أن تدفع China Shineway Pharmaceutical Group خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٠٫٤٩ CNY.

نسبة توزيعات الأرباح الحالية لـ China Shineway Pharmaceutical Group هي ٦٫٤٩ %.

China Shineway Pharmaceutical Group يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أكتوبر, مايو, يونيو, أكتوبر.

China Shineway Pharmaceutical Group دفعت توزيعات الأرباح كل عام خلال الـ22 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٠٫٤٩ CNY. وهذا يعادل عائد توزيعات أرباح قدره ٦٫٨١ %.

China Shineway Pharmaceutical Group يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٠٫١٢ CNY من China Shineway Pharmaceutical Group المُعلن عنها في ٢٧‏/٩‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ١٠‏/٩‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٢٧‏/٩‏/٢٠٢٤.

في العام 2023، وزعت China Shineway Pharmaceutical Group ٠٫٣٨٣ CNY كأرباح أسهم.

يتم توزيع أرباح China Shineway Pharmaceutical Group بالعملة CNY.